SCHEMBL21796351

SCHEMBL21796351

CC(Nc1nccnc1-c1ccc(NC(=O)Cc2ccc(C(F)(F)C(C)O)cc2)cc1)c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 3/20 0.40
▸ KCNJ5 P48544 1/20 0.40
▸ KCNJ3 P48549 1/20 0.40
▸ WNT3A P56704 1/20 0.39
▸ RORC P51449 3/20 0.38
▸ RET P07949 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37
▸ NCSTN Q92542 1/20 0.37
▸ APH1A Q96BI3 1/20 0.37
▸ PSENEN Q9NZ42 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19205763 1.00 TRPV1 (0.40) TRPV1KCNJ5KCNJ3WNT3ARORC
SCHEMBL19205595 0.90 KCNJ5 (0.42) TRPV1KCNJ5KCNJ3WNT3ARORC
SCHEMBL19205594 0.90 KCNJ5 (0.42) TRPV1KCNJ5KCNJ3WNT3ARORC
SCHEMBL21796350 0.88 RIPK1 (0.40) RORCRETMEN1KMT2ARIPK1
SCHEMBL19205749 0.88 RIPK1 (0.40) RORCRETMEN1KMT2ARIPK1
SCHEMBL22261805 0.88 RORC (0.42) RORCANO1RIPK1
SCHEMBL19205583 0.88 RORC (0.42) RORCANO1RIPK1
SCHEMBL21796353 0.86 NPC1 (0.42) RORCRETCYP2D6PSEN1PSEN2
SCHEMBL19205657 0.86 NPC1 (0.42) RORCRETCYP2D6PSEN1PSEN2
SCHEMBL18449666 0.85 RORC (0.44) TRPV1KCNJ5KCNJ3WNT3ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331863-B1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2020-03-11 — — EP claimed
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback